Evidence map›Paper›PMID 33851180›Full record

ArticlemedRxiv : the preprint server for health sciences2021

Quantitative SARS-CoV-2 viral-load curves in paired saliva and nasal swabs inform appropriate respiratory sampling site and analytical test sensitivity required for earliest viral detection.

Emily S Savela, Alexander Winnett, Anna E Romano, Michael K Porter, Natasha Shelby, Reid Akana, Jenny Ji, Matthew M Cooper, Noah W Schlenker, Jessica A Reyes and 6 more

Open access · greenAbstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 30 citations in OpenAlex.

  1. Sensitivity and specificity of the antigen-based anterior nasal self-testing programme for detecting SARS-CoV-2 infection in schools, Austria, March 2021.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2021
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 1 country.

Emily S SavelaCalifornia Institute of Technology, 1200 E. California Blvd., Pasadena, CA, USA 91125.
Alexander WinnettCalifornia Institute of Technology, 1200 E. California Blvd., Pasadena, CA, USA 91125.
Anna E RomanoCalifornia Institute of Technology, 1200 E. California Blvd., Pasadena, CA, USA 91125.
Michael K PorterCalifornia Institute of Technology, 1200 E. California Blvd., Pasadena, CA, USA 91125.
Natasha ShelbyCalifornia Institute of Technology, 1200 E. California Blvd., Pasadena, CA, USA 91125.
Reid AkanaCalifornia Institute of Technology, 1200 E. California Blvd., Pasadena, CA, USA 91125.
Jenny JiCalifornia Institute of Technology, 1200 E. California Blvd., Pasadena, CA, USA 91125.
Matthew M CooperCalifornia Institute of Technology, 1200 E. California Blvd., Pasadena, CA, USA 91125.
Noah W SchlenkerCalifornia Institute of Technology, 1200 E. California Blvd., Pasadena, CA, USA 91125.
Jessica A ReyesCalifornia Institute of Technology, 1200 E. California Blvd., Pasadena, CA, USA 91125.
Alyssa M CarterCalifornia Institute of Technology, 1200 E. California Blvd., Pasadena, CA, USA 91125.
Jacob T BarlowCalifornia Institute of Technology, 1200 E. California Blvd., Pasadena, CA, USA 91125.
Colten TognazziniCity of Pasadena Public Health Department, 1845 N. Fair Oaks Ave., Pasadena, CA, USA 91103.
Matthew FeasterCity of Pasadena Public Health Department, 1845 N. Fair Oaks Ave., Pasadena, CA, USA 91103.
Ying-Ying GohCity of Pasadena Public Health Department, 1845 N. Fair Oaks Ave., Pasadena, CA, USA 91103.
Rustem F IsmagilovCalifornia Institute of Technology, 1200 E. California Blvd., Pasadena, CA, USA 91125.
California Institute of Technology · USPasadena City College · US

Funding

UCLA-Caltech Medical Scientist Training ProgramT32GM008042 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI AJIJOLA, OLUJIMI A, DAWSON, DAVID WAYNE · 1985 to 2023
$29.9M
Predoctoral Biotechnology Leadership Training in Micro/NanomedicineT32GM112592 · NIGMS · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI ARNOLD, FRANCES H · 2015 to 2019
$1.1M
NIGMS NIH HHS T32 GM008042NIGMS NIH HHS T32 GM112592
6 · The paper itself

Abstract

Early detection of SARS-CoV-2 infection is critical to reduce asymptomatic and pre-symptomatic transmission, curb the spread of variants by travelers, and maximize treatment efficacy. Low-sensitivity nasal-swab testing (antigen and some nucleic-acid-amplification tests) is commonly used for surveillance and symptomatic testing, but the ability of low-sensitivity nasal-swab tests to detect the earliest stages of infection has not been established. In this case-ascertained study, initially-SARS-CoV-2-negative household contacts of individuals diagnosed with COVID-19 prospectively self-collected paired anterior-nares nasal-swab and saliva samples twice daily for viral-load quantification by high-sensitivity RT-qPCR and digital-RT-PCR assays. We captured viral-load profiles from the incidence of infection for seven individuals and compared diagnostic sensitivities between respiratory sites. Among unvaccinated persons, high-sensitivity saliva testing detected infection up to 4.5 days before viral loads in nasal swabs reached the limit of detection of low-sensitivity nasal-swab tests. For most participants, nasal swabs reached higher peak viral loads than saliva, but were undetectable or at lower loads during the first few days of infection. High-sensitivity saliva testing was most reliable for earliest detection. Our study illustrates the value of acquiring early (within hours after a negative high-sensitivity test) viral-load profiles to guide the appropriate analytical sensitivity and respiratory site for detecting earliest infections. Such data are challenging to acquire but critical to design optimal testing strategies in the current pandemic and will be required for responding to future viral pandemics. As new variants and viruses emerge, up-to-date data on viral kinetics are necessary to adjust testing strategies for reliable early detection of infections.

Indexed as

Case-ascertainedCOVID-19DiagnosticsHousehold studyLongitudinal samplingNasal swabPre-SymptomaticRT-qPCRSalivaSurveillanceTransmission

Identifiers

PMID33851180
PMCPMC8043477
OpenAlexW3141487834

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.